Inventor · disambiguated record
Nathanael S. Gray
Also filed as: GRAY NATHANAEL · GRAY NATHANAEL S · GRAY NATHANAEL SCHIANDER
189 granted patents·125 pending applications·1,636 citations·filing 1998–2025
99Inventor score
Files withDANA FARBER CANCER INST INC211IRM LLC42MASSACHUSETTS GEN HOSPITAL6GRAY NATHANAEL S5NOVARTIS AG5
Top patents by PatentIndex Score
314 records- 0197US11325910B2Inhibitors of cyclin-dependent kinasesDANA FARBER CANCER INST INC·Filed 2020·Granted May 10, 2022·8 cites·24 claims
- 0297US10550121B2Inhibitors of cyclin-dependent kinasesDANA FARBER CANCER INST INC·Filed 2016·Granted Feb 4, 2020·15 cites·10 claims
- 0397US9758522B2Hydrophobically tagged small molecules as inducers of protein degradationDANA FARBER CANCER INST INC·Filed 2013·Granted Sep 12, 2017·27 cites·22 claims
- 0497US9505784B2Fused 2-aminothiazole compoundsDANA FARBER CANCER INST INC·Filed 2014·Granted Nov 29, 2016·64 cites·27 claims
- 0596US9382239B2Inhibitors of c-Jun-N-terminal kinase (JNK)DANA FARBER CANCER INST INC·Filed 2012·Granted Jul 5, 2016·30 cites·47 claims
- 0696US7745437B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2005·Granted Jun 29, 2010·83 cites·8 claims
- 0796US7642255B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2008·Granted Jan 5, 2010·60 cites·6 claims
- 0895US11725011B2Bicyclic urea kinase inhibitors and uses thereofBROAD INST INC·Filed 2020·Granted Aug 15, 2023·4 cites·9 claims
- 0995US10287268B2Imidazolyl kinase inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2015·Granted May 14, 2019·11 cites·23 claims
- 1095US10144730B2Inhibitors of c-Jun-N-terminal kinase (JNK)DANA FARBER CANCER INST INC·Filed 2016·Granted Dec 4, 2018·16 cites·39 claims
- 1195US8552002B2Compounds and compositions as protein kinase inhibitorsDING QIANG·Filed 2005·Granted Oct 8, 2013·132 cites·43 claims
- 1294US11932625B2Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereofDANA FARBER CANCER INST INC·Filed 2022·Granted Mar 19, 2024·3 cites·30 claims
- 1394US10870651B2Inhibitors of cyclin-dependent kinase 7 (CDK7)DANA FARBER CANCER INST INC·Filed 2015·Granted Dec 22, 2020·9 cites·36 claims
- 1494US10544138B2Tricyclic kinase inhibitors of MELK and methods of useDANA FARBER CANCER INST INC·Filed 2016·Granted Jan 28, 2020·12 cites·20 claims
- 1594US10017477B2Janus kinase inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2015·Granted Jul 10, 2018·20 cites·27 claims
- 1694US9862688B2Hydrophobically tagged janus kinase inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2015·Granted Jan 9, 2018·22 cites·40 claims
- 1794US7750021B2Immunosuppressant compounds and compositionsIRM LLC·Filed 2008·Granted Jul 6, 2010·34 cites·8 claims
- 1894US7060697B2Immunosuppressant compounds and compositionsIRM LLC·Filed 2004·Granted Jun 13, 2006·67 cites·8 claims
- 1993US11040957B2Heteroaromatic compounds useful for the treatment of proliferative diseasesSYROS PHARMACEUTICALS INC·Filed 2018·Granted Jun 22, 2021·7 cites·21 claims
- 2093US10975058B2Imidazolyl kinase inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2019·Granted Apr 13, 2021·6 cites·32 claims
- 2193US10342798B2Fused bicyclic pyrimidine derivatives and uses thereofDANA FARBER CANCER INST INC·Filed 2016·Granted Jul 9, 2019·7 cites·42 claims
- 2293US9358231B2Type II RAF kinase inhibitorsDANA FARBER CANCER INST INC·Filed 2014·Granted Jun 7, 2016·22 cites·1 claims
- 2393US9180127B2Type II Raf kinase inhibitorsGRAY NATHANAEL S·Filed 2010·Granted Nov 10, 2015·24 cites·8 claims
- 2493US8921336B2Small molecule myristate inhibitors of BCR-ABL and methods of useGRAY NATHANAEL·Filed 2008·Granted Dec 30, 2014·12 cites·10 claims
- 2593US8889706B2Soluble mTOR complexes and modulators thereofWHITEHEAD BIOMEDICAL INST·Filed 2012·Granted Nov 18, 2014·31 cites·6 claims
- 2693US8394818B2Soluble mTOR complexes and modulators thereofGRAY NATHANAEL·Filed 2009·Granted Mar 12, 2013·40 cites·31 claims
- 2793US7589101B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2006·Granted Sep 15, 2009·30 cites·8 claims
- 2892US11306070B2Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereofDANA FARBER CANCER INST INC·Filed 2017·Granted Apr 19, 2022·8 cites·20 claims
- 2992US10787436B2Inhibitors of cyclin-dependent kinase 7 (CDK7)DANA FARBER CANCER INST INC·Filed 2018·Granted Sep 29, 2020·5 cites·37 claims
- 3092USRE48175EHydrophobically tagged small molecules as inducers of protein degradationDANA-FARBER CANCER INSTITUTE INC·Filed 2013·Granted Aug 25, 2020·9 cites·25 claims
- 3192US10695346B24,6-pyrimidinylene derivatives and uses thereofDANA FARBER CANCER INST INC·Filed 2016·Granted Jun 30, 2020·5 cites·32 claims
- 3292US10233157B2SIK inhibitor for use in a method of treating an inflammatory and/or immune disorderDANA FARBER CANCER INST INC·Filed 2017·Granted Mar 19, 2019·9 cites·26 claims
- 3392US10112927B2Inhibitors of cyclin-dependent kinase 7 (CDK7)DANA FARBER CANCER INST INC·Filed 2013·Granted Oct 30, 2018·19 cites·20 claims
- 3492US9783504B2Kinase inhibitors for the treatment of diseaseDANA FARBER CANCER INST INC·Filed 2014·Granted Oct 10, 2017·21 cites·27 claims
- 3592US7893074B22, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disordersNOVARTIS AG·Filed 2004·Granted Feb 22, 2011·55 cites·9 claims
- 3691US10981903B2Inhibitors of c-Jun-N-terminal kinase (JNK)DANA FARBER CANCER INST INC·Filed 2018·Granted Apr 20, 2021·4 cites·32 claims
- 3791US10265321B2Uses of salt-inducible kinase (SIK) inhibitorsDANA FARBER CANCER INST INC·Filed 2017·Granted Apr 23, 2019·10 cites·38 claims
- 3891US10047070B2Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)DANA FARBER CANCER INST INC·Filed 2014·Granted Aug 14, 2018·17 cites·19 claims
- 3991US9879003B2Host targeted inhibitors of dengue virus and other virusesHARVARD COLLEGE·Filed 2013·Granted Jan 30, 2018·20 cites·25 claims
- 4091US9695172B2Diazepane derivatives and uses thereofDANA FARBER CANCER INST INC·Filed 2015·Granted Jul 4, 2017·13 cites·74 claims
- 4191US9670165B2SIK inhibitor for use in a method of treating an inflammatory and/or immune disorderUNIV COURT OF THE UNIV OF DUNDEE·Filed 2013·Granted Jun 6, 2017·33 cites·20 claims
- 4291US8987275B2Indazole compounds and their usesGRAY NATHANAEL·Filed 2011·Granted Mar 24, 2015·22 cites·28 claims
- 4391US8765747B2Fused 2-aminothiazole compoundsCHOI HWAN GEUN·Filed 2010·Granted Jul 1, 2014·33 cites·31 claims
- 4491US7176312B2Kinase inhibitor scaffolds and methods for their preparationIRM LLC·Filed 2002·Granted Feb 13, 2007·25 cites·20 claims
- 4590US12098154B2Inhibitors of cyclin-dependent kinasesDANA FARBER CANCER INST INC·Filed 2022·Granted Sep 24, 2024·1 cites·37 claims
- 4690US10954242B2Bicyclic urea kinase inhibitors and uses thereofBROAD INST INC·Filed 2017·Granted Mar 23, 2021·9 cites·33 claims
- 4790US10316002B2Kinase inhibitors for the treatment of diseaseDANA FARBER CANCER INST INC·Filed 2017·Granted Jun 11, 2019·9 cites·18 claims
- 4890US9879028B2Compounds that modulate EGFR activity and methods for treating or preventing conditions therewithGATEKEEPER PHARMACEUTICALS INC·Filed 2013·Granted Jan 30, 2018·12 cites·11 claims
- 4990US9676792B2Pyrimido-diazepinone compounds and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2014·Granted Jun 13, 2017·12 cites·6 claims
- 5090US7939519B2Immunosuppresant compounds and compositionsNOVARTIS AG·Filed 2008·Granted May 10, 2011·14 cites·2 claims
Showing the top 50 of 314 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Nathanael S. Gray files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →